Scholar Rock Holding Corp (SRRK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Scholar Rock Holding Corp (SRRK) has a cash flow conversion efficiency ratio of -0.281x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-68.92 Million) by net assets ($245.00 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Scholar Rock Holding Corp - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Scholar Rock Holding Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SRRK current and long-term liabilities for a breakdown of total debt and financial obligations.
Scholar Rock Holding Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Scholar Rock Holding Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hunan Valin Steel Co Ltd
SHE:000932
|
0.034x |
|
Companhia Energética de Minas Gerais
MX:CIGN
|
-0.059x |
|
First Capital Securities Co Ltd Class A
SHE:002797
|
0.035x |
|
Guoyuan Securities Co Ltd
SHE:000728
|
0.038x |
|
Mobile World Investment Corp
VN:MWG
|
-0.018x |
|
Millrose Properties, Inc.
NYSE:MRP
|
0.043x |
|
Nanning Chemical Industry Co Ltd
SHG:600301
|
0.065x |
|
RTL GROUP UNSP.ADR 10
F:RRTU
|
N/A |
Annual Cash Flow Conversion Efficiency for Scholar Rock Holding Corp (2016–2024)
The table below shows the annual cash flow conversion efficiency of Scholar Rock Holding Corp from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see SRRK stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $368.63 Million | $-200.95 Million | -0.545x | +15.46% |
| 2023-12-31 | $225.22 Million | $-145.23 Million | -0.645x | -26.46% |
| 2022-12-31 | $260.24 Million | $-132.69 Million | -0.510x | +30.80% |
| 2021-12-31 | $172.07 Million | $-126.79 Million | -0.737x | -218.80% |
| 2020-12-31 | $260.77 Million | $-60.27 Million | -0.231x | +58.66% |
| 2019-12-31 | $112.90 Million | $-63.12 Million | -0.559x | -342.58% |
| 2018-12-31 | $106.62 Million | $24.57 Million | 0.230x | -43.26% |
| 2017-12-31 | $-53.52 Million | $-21.74 Million | 0.406x | -19.46% |
| 2016-12-31 | $-30.03 Million | $-15.14 Million | 0.504x | -- |
About Scholar Rock Holding Corp
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to deve… Read more